Qin W, Liu Z, Huang M, Liang L, Gan Y, Huang Z
Int J Mol Sci. 2025; 26(4).
PMID: 40003893
PMC: 11855556.
DOI: 10.3390/ijms26041425.
Hou D, Zhou H, Tang Y, Liu Z, Su L, Guo J
Drug Des Devel Ther. 2025; 19:1043-1065.
PMID: 39974609
PMC: 11837852.
DOI: 10.2147/DDDT.S497126.
Amarasiri H, Arachchige D, Vince M, Holub J
J Mol Recognit. 2025; 38(2):e70001.
PMID: 39905677
PMC: 11794977.
DOI: 10.1002/jmr.70001.
van Wier S, Beekman A
Chem Soc Rev. 2025; 54(4):1684-1698.
PMID: 39817557
PMC: 11736853.
DOI: 10.1039/d4cs00243a.
Moreno-Vargas L, Prada-Gracia D
Int J Mol Sci. 2025; 26(1.
PMID: 39795918
PMC: 11720145.
DOI: 10.3390/ijms26010059.
pH-Responsive Peptide Nanoparticles Deliver Macromolecules to Cells via Endosomal Membrane Nanoporation.
Wu E, Ellis A, Bell K, Moss D, Landry S, Hristova K
ACS Nano. 2024; 18(50):33922-33936.
PMID: 39651582
PMC: 11656837.
DOI: 10.1021/acsnano.4c07525.
Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review.
Saxena R, Welsh C, He Y
Front Cell Dev Biol. 2024; 12:1462339.
PMID: 39620145
PMC: 11604647.
DOI: 10.3389/fcell.2024.1462339.
A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint.
Naylon S, Richaud A, Zhao G, Bui L, Dufresne C, Wu C
RSC Chem Biol. 2024; .
PMID: 39552936
PMC: 11562385.
DOI: 10.1039/d4cb00174e.
Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors.
Qiao Z, Nguyen L, Yang D, Dann C, Thomas D, Henn M
Nat Chem Biol. 2024; 21(2):247-255.
PMID: 39215099
DOI: 10.1038/s41589-024-01716-z.
Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTAC.
Whittaker M, Bendzunas G, Shirani M, LeClair T, Shebl B, Dill T
ACS Chem Biol. 2024; 19(9):1888-1895.
PMID: 39137166
PMC: 11420944.
DOI: 10.1021/acschembio.4c00237.
Dissecting the neuroprotective interaction between the BH4 domain of BCL-w and the IP3 receptor.
Tang S, Camara C, Franco J, Pazyra-Murphy M, Li Y, Godes M
Cell Chem Biol. 2024; 31(10):1815-1826.e5.
PMID: 39067448
PMC: 11490406.
DOI: 10.1016/j.chembiol.2024.06.016.
Molecular Modeling of Single- and Double-Hydrocarbon-Stapled Coiled-Coil Inhibitors against Bcr-Abl: Toward a Treatment Strategy for CML.
Lima M, Hornsby B, Lim C, Cheatham 3rd T
J Phys Chem B. 2024; 128(27):6476-6491.
PMID: 38951498
PMC: 11247501.
DOI: 10.1021/acs.jpcb.4c02699.
Peptide macrocyclisation intramolecular interception of visible-light-mediated desulfurisation.
Smith F, Meehan D, Griffiths R, Knowles H, Zhang P, Williams H
Chem Sci. 2024; 15(25):9612-9619.
PMID: 38939126
PMC: 11206203.
DOI: 10.1039/d3sc05865d.
Comparing Cell Penetration of Biotherapeutics across Human Cell Lines.
Batistatou N, Kritzer J
ACS Chem Biol. 2024; 19(6):1351-1365.
PMID: 38836425
PMC: 11687341.
DOI: 10.1021/acschembio.4c00211.
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges.
Zhang Z, Hou L, Liu D, Luan S, Huang M, Zhao L
Acta Pharm Sin B. 2024; 14(6):2378-2401.
PMID: 38828138
PMC: 11143528.
DOI: 10.1016/j.apsb.2024.02.010.
Synthesis of Membrane-Permeable Macrocyclic Peptides via Imidazopyridinium Grafting.
Li B, Parker J, Tong J, Kodadek T
J Am Chem Soc. 2024; 146(21):14633-14644.
PMID: 38752889
PMC: 11705912.
DOI: 10.1021/jacs.4c01920.
Site-Specifically Modified Peptide Inhibitors of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase with Enhanced Stability and Improved In Vivo Long-Acting Activity.
Zhang C, Yang X, Wu L, Liu F, Dong K, Guo C
ACS Pharmacol Transl Sci. 2024; 7(5):1426-1437.
PMID: 38751623
PMC: 11091969.
DOI: 10.1021/acsptsci.4c00054.
Another side of side chains.
Chen F
Nat Rev Chem. 2024; 8(6):406-407.
PMID: 38698144
DOI: 10.1038/s41570-024-00609-y.
Non-symmetric stapling of native peptides.
Chen F, Lin W, Chen F
Nat Rev Chem. 2024; 8(5):304-318.
PMID: 38575678
DOI: 10.1038/s41570-024-00591-5.
In silico design of potential Mcl-1 peptide-based inhibitors.
Faraji N, Daly N, Arab S, Khosroushahi A
J Mol Model. 2024; 30(4):108.
PMID: 38499818
DOI: 10.1007/s00894-024-05901-8.